Cite
Ankrom W, Wood HB, Xu J, et al. Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target. Pharmacol Res Perspect. 2016;4(1):e00207doi: 10.1002/prp2.207.
Ankrom, W., Wood, H. B., Xu, J., Geissler, W., Bateman, T., Chatterjee, M. S., Feng, K. I., Metzger, J. M., Strapps, W. R., Tadin-Strapps, M., Seiffert, D., & Andre, P. (2016). Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target. Pharmacology research & perspectives, 4(1), e00207. https://doi.org/10.1002/prp2.207
Ankrom, Wendy, et al. "Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target." Pharmacology research & perspectives vol. 4,1 (2016): e00207. doi: https://doi.org/10.1002/prp2.207
Ankrom W, Wood HB, Xu J, Geissler W, Bateman T, Chatterjee MS, Feng KI, Metzger JM, Strapps WR, Tadin-Strapps M, Seiffert D, Andre P. Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target. Pharmacol Res Perspect. 2016 Jan 15;4(1):e00207. doi: 10.1002/prp2.207. eCollection 2016 Feb. PMID: 26977298; PMCID: PMC4777260.
Copy
Download .nbib